Evaluation of morning bradykinesia in Parkinson’s disease in a United States cohort using continuous objective monitoring

INTRODUCTION: Bradykinesia in Parkinson’s disease is a marker for clinical levodopa responsiveness, with persistent bradykinesia reflecting suboptimal response. We objectively measured prevalence and severity of morning bradykinesia using the Personal KinetiGraph® (PKG®). METHODS: Retrospective eval...

Descripción completa

Detalles Bibliográficos
Autores principales: Isaacson, S.H., Pahwa, R., Pappert, E.J., Torres-Russotto, D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9127405/
https://www.ncbi.nlm.nih.gov/pubmed/35620251
http://dx.doi.org/10.1016/j.prdoa.2022.100145

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9127405/
https://www.ncbi.nlm.nih.gov/pubmed/35620251
http://dx.doi.org/10.1016/j.prdoa.2022.100145

Ejemplares similares